Home › Compare › DZCA vs JNJ

DZCA vs JNJ: Dividend Comparison 2026

DZCA yields 15384.62% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DZCA wins by $3891550444739779072.00M in total portfolio value
10 years
DZCA
DZCA
● Live price
15384.62%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3891550444739779072.00M
Annual income
$3,842,419,411,100,930,600,000,000.00
Full DZCA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DZCA vs JNJ

📍 DZCA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDZCAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DZCA + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DZCA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DZCA
Annual income on $10K today (after 15% tax)
$1,307,692.31/yr
After 10yr DRIP, annual income (after tax)
$3,266,056,499,435,791,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DZCA beats the other by $3,266,056,499,435,791,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DZCA + JNJ for your $10,000?

DZCA: 50%JNJ: 50%
100% JNJ50/50100% DZCA
Portfolio after 10yr
$1945775222369889536.00M
Annual income
$1,921,209,705,550,465,300,000,000.00/yr
Blended yield
98.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DZCA
No analyst data
Altman Z
-12.5
Piotroski
0/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DZCA buys
0
JNJ buys
0
No recent congressional trades found for DZCA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDZCAJNJ
Forward yield15384.62% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$3891550444739779072.00M ✓$20.0K
Annual income after 10y$3,842,419,411,100,930,600,000,000.00 ✓$827.78
Total dividends collected$3888300422505230336.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DZCA vs JNJ ($10,000, DRIP)

YearDZCA PortfolioDZCA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,549,162$1,538,461.54$10,676$355.77+$1.54M → DZCA
2$224,398,299$222,740,695.68$11,407$389.39+$224.39M → DZCA
3$30,393,669,947$30,153,563,768.04$12,198$426.53+$30393.66M → DZCA
4$3,849,488,649,772$3,816,967,422,928.51$13,056$467.62+$3849488.64M → DZCA
5$455,927,638,969,499$451,808,686,114,242.40$13,987$513.12+$455927638.96M → DZCA
6$50,498,628,024,446,920$50,010,785,450,749,560.00$14,998$563.56+$50498628024.43M → DZCA
7$5,230,859,393,138,899,000$5,176,825,861,152,740,000.00$16,098$619.52+$5230859393138.88M → DZCA
8$506,753,379,075,556,640,000$501,156,359,524,898,000,000.00$17,295$681.69+$506753379075556.63M → DZCA
9$45,916,853,868,083,470,000,000$45,374,627,752,472,630,000,000.00$18,599$750.82+$45916853868083464.00M → DZCA
10$3,891,550,444,739,779,000,000,000$3,842,419,411,100,930,600,000,000.00$20,022$827.78+$3891550444739779072.00M → DZCA

DZCA vs JNJ: Complete Analysis 2026

DZCA — Stock

DrazCanna, Inc., doing business as a Global Personalized Academics, operates as an education company that provides virtual and classroom learning solutions to students and teachers worldwide. The company offers digital curriculum, including core, electives, AP, world language, and credit recovery courses for K-12 grade students; online and face-to-face professional teacher training; access to learning management software; end-to-end online school solutions, such as online courses, learning management systems, and a teacher for tuition on per student and per semester basis; and international dual-diploma courses. It serves approximately 150 school districts in the United States. The company was formerly known as Sibling Group Holdings, Inc. and changed its name to DrazCanna, Inc. in March 2022. DrazCanna, Inc. was founded in 2010 and is headquartered in Orlando, Florida.

Full DZCA Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DZCA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DZCA vs SCHDDZCA vs JEPIDZCA vs ODZCA vs KODZCA vs MAINDZCA vs ABBVDZCA vs MRKDZCA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.